However, these blockers inhibit both IL-1β and IL-1α, but IL-1α can have tumor promoting or inhibiting functions, and inhibiting this isoform together with IL-1β can have synergistic or antagonist effects, depending on the context. This evidence concerns the gene IL1B and neoplasm.